Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsprostate cancer variants・B7-H3 biomarker・renal cell carcinoma immunotherapy・Birt-Hogg-Dube syndrome・folliculin deficiency・DICER1-mutant rhabdomyosarcoma・mismatch repair deficiency

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Lipid cell and micropapillary variants of urothelial carcinoma of the ureter
• Lower neutrophil-to-lymphocyte ratio and positive programmed cell death ligand-1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma.
• The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis.
• Fluorescence Detection of Prostate Cancer by an Activatable Fluorescence Probe for PSMA Carboxypeptidase Activity.

• 2024/04～ 婦人科腫瘍における新興の概念である中腎様腺癌の独立性を探求する 2024年度 若手研究2024 · 研究課題・受託研究・科研費
• 婦人科腫瘍における新興の概念である中腎様腺癌の独立性を探求する

• Official profile